Table 3.
Variable | All patients (n=222) | Functional improvement |
Relief of back pain |
|||||
---|---|---|---|---|---|---|---|---|
Satisfied (n=206) | Dissatisfied (n=16) | p-value | Satisfied (n = 213) | Dissatisfied (n = 9) | p-value | |||
ODI score | ||||||||
Baseline | 44.8 ± 19.9 | 45.6 ± 19.8 | 34.4 ± 18.8 | 0.030** | 45.1 ± 19.8 | 34.4 ± 22.5 | 0.329 | |
At 2 years | 3.2 ± 7.4 | 1.5 ± 3.2 | 24.8 ± 11.5 | < 0.001** | 2.2 ± 5.0 | 26.4 ± 14.5 | 0.005** | |
SF-36 PF score | ||||||||
Baseline | 52.1 ± 23.5 | 51.2 ± 23.1 | 64.7 ± 25.1 | 0.026** | 51.7 ± 23.4 | 62.2 ± 24.5 | 0.189 | |
At 2 years | 97.5 ± 5.1 | 98.5 ± 2.7 | 84.4 ± 9.6 | < 0.001** | 98.1 ± 3.7 | 82.8 ± 10.9 | 0.003** | |
SF-36 BP score | ||||||||
Baseline | 46.5 ± 19.0 | 45.7 ± 19.1 | 57.4 ± 14.7 | 0.017** | 46.0 ± 19.1 | 59.6 ± 13.1 | 0.035** | |
At 2 years | 96.0 ± 9.3 | 98.0 ± 5.0 | 70.1 ± 12.7 | < 0.001** | 97.2 ± 7.1 | 68.0 ± 11.8 | < 0.001** | |
EQ-5D score | ||||||||
Baseline | 0.53 ± 0.22 | 0.52 ± 0.23 | 0.63 ± 0.15 | 0.063* | 0.52 ± 0.22 | 0.66 ± 0.13 | 0.070* | |
At 2 years | 0.97 ± 0.07 | 0.99 ± 0.04 | 0.80 ± 0.12 | < 0.001** | 0.98 ± 0.05 | 0.77 ± 0.12 | < 0.001** | |
VAS-back score | ||||||||
Baseline | 3.94 ± 2.42 | 3.96 ± 2.42 | 3.69 ± 2.50 | 0.668 | 3.94 ± 2.42 | 3.89 ± 2.47 | 0.950 | |
At 2 years | 0.37 ± 0.86 | 0.20 ± 0.50 | 2.56 ± 1.41 | < 0.001** | 0.23 ± 0.51 | 3.67 ± 0.87 | < 0.001** | |
VAS-leg score | ||||||||
Baseline | 5.40 ± 1.92 | 5.40 ± 1.96 | 5.38 ± 1.41 | 0.963 | 5.42 ± 1.92 | 4.78 ± 2.12 | 0.326 | |
At 2 years | 0.19 ± 0.56 | 0.09 ± 0.31 | 1.44 ± 1.21 | < 0.001** | 0.15 ± 0.49 | 1.11 ± 1.17 | 0.038** |
Values are presented as mean±standard deviation.
ODI, Oswestry Disability Index; SF-36 PF; 36-item Short Form Health Survey physical function; SF-36 BP, 36-item Short Form Health Survey bodily pain; EQ-5D, European quality of life-5 dimensions; VAS, visual analogue scale.
p<0.1.
p<0.05.